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In the last 20 years, a pituitary-hypothalamus tissue culture system with intact neural and portal connections has been developed
in our lab and used to understand the feedback mechanisms that regulate the secretions of adenohypophyseal hormones and
fertility of male rats. In the last decade, several in vivo rat models have also been developed in our lab with a view to substantiate
the in vitro ﬁndings, in order to delineate the role of pituitary hormones in the regulation of fertility of male rats. These studies
have relied on both surgical and pharmacological interventions to modulate the secretions of gonadotropins and testosterone.
The interrelationship between the circadian release of reproductive hormones has also been ascertained in normal men. Our
studies suggest that testosterone regulates the secretion of prolactin through a long feedback mechanism, which appears to have
been conserved from rats to humans. These studies have ﬁlled in a major lacuna pertaining to the role of prolactin in male
reproductive physiology by demonstrating the interdependence between testosterone and prolactin. Systemic levels of prolactin
play a deterministic role in the mechanism of chromatin condensation during spermiogenesis.
Copyright © 2009 M. K. Gill-Sharma. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Male fertility in mammals is regulated by the two ade-
nohypophyseal hormones, luteinizing hormone (LH) and
follicle stimulating hormone (FSH), through synthesis of
testosterone in the interstitial cells of Leydig and its arom-
atization to estradiol in the Sertoli cells of the testis.
The regulated release of the hypothalamic gonadotropin-
releasing hormone (GnRH) ensures normal functioning of
the hypothalamo-hypophysio-gonadal axis, through secre-
tion of gonadotropins and testosterone in systemic circu-
lation, necessary for spermatogenesis, maturation of sper-
matozoa, and reproductive behaviour [1, 2]. Prolactin,
a 23Kd hormone, synthesized in the adenohypophyseal
lactotrophs, has no known target organ or deﬁned role in
male reproduction. Yet, expression of prolactin receptors on
choroid plexuses and hypothalamus presupposes a latent
role for this hormone in the regulation of male fertility
[3, 4]. In particular, advancement of knowledge in the
area of prolactin signaling cascades across species suggests
a conserved physiological role from rodents to humans
[5]. Although the functional signiﬁcance of prolactin to
male reproduction has not been unequivocally established,
the hormone has been associated primarily with male
infertility. Acute hyperprolactinemia is known to suppress
testosterone synthesis and male fertility through prolactin-
induced hypersecretion of adrenal corticoids or by inhibiting
the secretion of GnRH through prolactin receptors on
hypothalamic dopaminergic neurons [6, 7]. Dopamine has
been implicated in the release of endorphins from opiatergic
neurons that inhibit the secretion of GnRH [8].
Since a clear consensus about the involvement of pro-
lactin in male reproduction has not emerged even from
genetically engineered mouse models wherein prolactin
signaling has been disrupted, not enough attention has
been focused on the regulation of its secretion [9, 10].
However, the absence of detrimental eﬀects on male fertility
in prolactin receptor-deﬁcient mice does not preclude a
role for prolactin, but rather indicates the existence of
compensatory mechanisms reported in literature for certain
genetically modiﬁed mouse models [11, 12]. Albeit, geneti-
cally modiﬁed mice overexpressing prolactin, could prove to2 International Journal of Endocrinology
be alternative models in understanding the physiological role
of this hormone in modulating male fertility [13]. A host
of releasing and release-inhibiting factors of pituitary and
hypothalamic origin have been suggested to be involved in
prolactin secretion but their physiological relevance in male
reproduction remains a moot point. Dopamine remains the
only acceptable negative regulator of prolactin secretion of
physiological relevance [14]. Prolactin primarily regulates its
own release via a short feedback loop through autorecep-
tors on the hypothalamic tuberoinfundibular dopaminergic
neurons (TIDA), which release dopamine (DA) into the long
portal vessels [15]. Dopamine reaches the adenohypophysis
through pituitary portal circulation where its inhibitory
eﬀects are mediated via cognate D2 dopaminergic receptors
on the lactotrophs [16]. Among the gonadal steroids, high
estradiol levels appear to render the dopaminergic neurons
refractory to prolactin autofeedback making it improbable
to reverse the eﬀects of physiological or pathological hyper-
prolactinemia [17–19]. In such an eventuality, it is tempting
to assume that additional androgen-dependent feedback
mechanisms might be involved in restraining the secretion
of prolactin, which has a propensity for hypersecretion [20].
Conventionally, prolactin is without a target organ
and, therefore, not subject to long feedback regulation.
However, prolactin has also been reported to play a role in
the synthesis of testosterone through upregulation of LH
receptors on Leydig cells but the relevance of this mechanism
to reproductive physiology has not been understood [21,
22]. Testosterone is known to be involved in the feedback
inhibitionofLH,thehormoneresponsibleforitssynthesisin
the testis [23]. By analogy, it is again tempting to assume that
a similar mechanism of feedback inhibition by testosterone
could also exist for prolactin. Such a mechanism could
conceivably be playing a vital role in male reproductive
physiologybymodulatingprolactinandtestosteronelevelsin
systemic circulation under conditions of mild-to-moderate
hyperprolactinemia arising out of emotional or chemical
stress. Thus, in view of the doubtful signiﬁcance of prolactin
in the regulation of male fertility, lacunae continue to persist
pertaining to mechanisms underlying its secretion. Towards
this end, in vitro and in vivo models developed in our lab
have focused on this aspect. Several novel ﬁndings about
feedback mechanisms have emerged from these studies that
suggest a modulatory role for prolactin in the regulation of
male fertility.
2. Hypothalamo Hypophyseal-Gonadal Factors
UnderlyingProlactinSecretion
Prolactin secretion is regulated by factors originating from
the hypothalamus, the hypophysis, and the testes in the
male rats. These factors are either inhibitory or stimulatory
in action such that their cumulative eﬀect determines the
systemic levels of this hormone. The hypothalamic input
to the pituitary could be in the form of hypothalamic-
inhibitoryactivity(HPIA)orhypothalamic-releasingactivity
(HPRA). The physiological relevance of inhibitory and stim-
ulatory factors remains to be unequivocally demonstrated.
Figure 1: A photograph of a freshly dissected pituitary-
hypothalamus complex (PHC) from a normal adult male rat killed
5 minutes, following intracardiac injection of India ink [24].
Towards this end, we have used an in vitro organ culture
system comprising the rat hypothalamus and pituitary in
anatomic juxtaposition to establish the existence of complex
interactions between putative factors from both organs.
The development of the rat pituitary-hypothalamus tissue
culture (PHc) with intact neural connections and portal
plexus in our lab in 1985 was a major advancement
in reproductive Neuroendocrinology that spawned several
studies designed to understand the feedback regulation of
pituitary hormones in vitro [24]. The hypothalamic island,
demarcated by cutting along the lateral hypothalamic sulci,
posterior edge of the optic chiasma, and the anterior edge
of the mammillary bodies, was lifted from its seat on the
Sella turcica with an undercut 2-3mm in depth, along
with the pituitary attached to it via hypophyseal stalk
(see Figure 1). PHc comprises all the major dopaminergic
perikarya viz. Tuberoinfundibular (TIDA), periventricular
(PHDA), tuberohypophyseal (THDA), as well as the long
and short portal vessels [25, 26]. PHc and intact pituitaries
(PI) were incubated in Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM), fortiﬁed with nonessential amino acids, 3mM
NaHCO3 and 0.1M HEPES (4-(2-hydroxyethyl)-piperazine-
1-ethansulfonic) acid, and 0.1% bovine serum albumin at
37◦C for periods that varied from 1–72 hours depending on
the experiment. The hormones were assayed in the media,
blood, or pituitary homogenates by radioimmunoassays.
Surgical interventions like castration from 1–46 days, chem-
ical treatments like in vitro exposure to testosterone, or
pharmacological exposure to drugs in vivo were routinely
employed to manipulate the hormonal status.
2.1. Hypothalamic Factors. Dutt et al. (1986) ﬁrst used
the adult rat PHc cultures as the method of choice to
study the inhibitory inﬂuence of hypothalamus over theInternational Journal of Endocrinology 3
Table 1: Release of Prolactin by diﬀerent pituitary constructs in vitro.
System Whole pituitary Whole pituitary Pituitary-hypothalamus
Plus hypothalamus complex
Incubation(h) Totala Per hb Totala Per hb Totala Per hb
2 371.3 ±42.9 185.6 ±21.5 281.4 ± 22.9 140.7 ± 11.5 227.9 ±28.9b 113.9 ± 14.4
4 360.2 ±34.69 0 ±8.7∗∗ 294.9 ± 31.17 3 .7 ±7.8∗ 345.4 ±21.9∗∗ 86.4 ± 5.5
6 437.8 ±56.67 2 .5 ±9.4∗ 401.9 ±24.3∗∗ 67 ±4.1∗ 270.4 ±30.7c 45 ±5.1∗
Pituitary constructs were incubated in DMEM at 37◦C for 4 hours, in replicates of 10, at each time interval. Prolactin was assayed in spent medium by RIA.
Values are expressed as mean ± SEM. ang Prl (NIAMDD-RP-2); ∗P<. 001, ∗∗P<. 01, with respect to levels at 2 hours; bP<. 02, cP<. 05, with respect to
corresponding pituitary levels [27].
kinetics of secretion of prolactin from the adenohypophyseal
lactotrophs in vitro [27]. The authors observed that intact
pituitary released comparable amounts of prolactin from
2 to 6 hours in vitro. The hourly basal rate of prolactin
release decreased from 2 to 6 hours of incubation (Table 1).
Coincubation with the hypothalamus neither suppressed the
amounts secreted nor altered the rate of pituitary prolactin
secretion from 2–6 hours. The data was interpreted to
suggest that the hypothalamic prolactin releasing factors
(PRFs) were necessary to maintain the basal secretion
of prolactin from the pituitary glands. The secretion of
prolactin from PHc was observed to be considerably lower
than that from intact pituitary or coincubates. The rate of
prolactin release from PHc decreased from 4 to 6 hours. It
could be inferred from the comparative kinetics of prolactin
secretion from intact pituitary and PHc cultures that when
the portal connections were maintained in vitro between
the adeno- and neurohypophyses and the neural and portal
connections maintained with the hypothalamus, the rate of
p r o l a c t i ns e c r e t i o nw a sm o r ep h y s i o l o g i c a lb e c a u s eo ft h e
availability of the hypothalamic PRFs and PIFs. However, the
functionalityofthedopaminergicinhibitoryreceptorsonthe
lactotrophs in the PHc culture model only became evident
whenthesesystemswerechallengedwithadoseof1×10
−7 M
dopamine invitro. OnlythePHcresponded tothedopamine
challenge and exhibited a decrease in the rate of prolactin
secretion.
Dopamine has been shown to inhibit the release of
p r o l a c t i ni nav a r i e t yo fi nv i t r os y s t e m s[ 28–32]. In another
set of experiments designed to further validate PHc as a
model system of choice to study prolactin release, Dutt et al.
(1992) compared the eﬀects of dopamine, its agonists and
antagonists in PHc, whole pituitary (PI), adenohypophysis
(P-N), P-N+PP (posterior pituitary) cultures from normal
and reserpine-treated (prolactin depleted) rats [33]. The
authors observed that as compared to the other systems,
PHc, which released less prolactin than the other systems,
also responded adequately to agonists like 10
−7 M dopamine,
10
−7 M Bromocriptine, 8 × 10
−7 M Apomorphine with
suppression, and antagonists like 5 × 10
−8 M Perphenazine
with stimulation of prolactin release, even after reserpine-
induced depletion of lactotrophs (Table 2). The authors
concluded that if the intact portal and neural connections
between the anterior and posterior lobes of the pituitary
and the hypothalamus were not maintained, the dopamin-
ergic receptors on the lactotrophs no longer responded to
dopamine challenge in vitro, since the latter hormone, if
not stored in the posterior pituitary, got degraded rapidly
[34]. It was inferred from these studies that prolactin
had a characteristic pattern of release in vivo which was
dependent on the delivery of hypothalamic PRFs and PIFs
to the neurohypophysis through neural connections and
reached the adenohypophysis through neurohypophyseal
portal capillaries. Functional pituitary DA receptors were
absolutely essential for the dopaminergic inhibitory mech-
anism to operate, both in vitro and in vivo, for maintaining
homeostasis of prolactin.
Having established the suitability of the PHc cultures
for studying the regulation of prolactin secretion in vitro,
Karanth et al. (1987) used the rat PHc and PI cultures
to establish the ontogenetic pattern of maturation of the
hypothalamic releasing and release-inhibiting activities that
regulateitssystemiclevelsatadulthood[35].Severalendoge-
nous factors have been reported to stimulate prolactin
secretion viz. Serotonin, β endorphin, Met enkephalin, Leu-
enkephalin, thyrotropin-releasing hormone (TRH), luteiniz-
ing hormone releasing hormone (LHRH), substance P, vaso-
pressin, oestradiol-17-β, epidermal growth factor, ﬁbroblast
growthfactor,cholecystokinin,andangiotensinII,prolactin-
releasing peptides (PrRPs) by direct action at the pituitary
level [36–40]. To qualify as PRFs, these factors would have
to override the inhibitory control of prolactin secretion by
physiological PIFs like dopamine and GABA [41–43]. The
prolactin released by the intact pituitary in vitro is a measure
of unregulated release whereas that secreted by PHc in vitro
is the cumulative eﬀect of physiological PRFs. Dutt et al.
(1986) assumed that since PHc secreted less prolactin than
intact hypophysis in vitro, the diﬀerence in the amount
released by the two systems would reﬂect the cumulative
hypothalamic PIF activity (HPIA) whereas that secreted by
PHc should be a true reﬂection of hypothalamic PRF activity
[27]. Karanth et al. (1987) used PHc and PI cultures to
validate this hypothesis. They attempted to correlate the
developmental changes in the HPRA and HPIA activities in
terms of prolactin released from PHc and PI in vitro from
postnatal day 7 to 77, to the age-related changes in the serum
prolactin levels in male rats,as reported in literature [35, 44].
The pituitary weights and prolactin content increased from
day 7 to 70 but was maintained thereafter in adult rats.
The weight of the hypothalamus increased from postnatal
day 7 to 56 before stabilization at maturity. Serum prolactin
levels underwent age-related increase from birth to 77 days4 International Journal of Endocrinology
Table 2: Eﬀects of reserpine on prolactin secretion by diﬀerent pituitary constructs in response to dopamine agonists and antagonists in
vitro.
Additions Control Reserpine 1.5mg/kg/d
In 25% Ascorbic acid in 25% ascorbic acid
(in vitro) PI P-N PHc PI P-N PHc
Ascorbic acid 429 ± 14.8 702 ± 8.54c 316 ± 7.59 126 ± 1.9b 126 ± 3.8b 167 ± 4.4bc
(0.05%)
Dopamine 344 ± 12.34 219 ± 11.39a 124 ± 2.85a 50 ± 1.27ab 71 ± 3.8ab 59 ± 1.9ab
10
−7 M
Bromocriptine 317 ± 10.12 339 ± 5.38a 161 ± 5.06a 46 ± 2.53ab 56 ± 3.8ab 50 ± 1.9ab
10
−7 M
Apomorphine 364 ± 5.06 108 ± 5.38a 108 ± 11.71a 40 ± 1.27ab 60 ± 2.53ab 30 ± 1.27b
8 ×10
−7 M
Perphenazine 393±10.12 694 ± 3.8c 466 ± 5.7∗ 140 ± 3.8 140 ± 6.96 330 ± 5.7∗
5 ×10
−7 M
Reserpinewasdissolvedin25%ascorbicacidandadministereds.ctoadultmaleratsfor46hours.Controlgroupratsreceivedvehiclealone.Diﬀerentpituitary
constructs were dissected out in DMEM and incubated at 37◦C for 4 hours, in replicates of 10, at each time interval. Prolactin was assayed in spent medium
by RIA. Values are expressed as mean (ng NIDDK-RAT-PRL-RP-3−ml incubation medium) ± SEM. asigniﬁcant diﬀerence with respect to 0.05% ascorbic acid
(P ≤ .05). bsigniﬁcant diﬀerence with respect to 25% ascorbic acid control group (P ≤ .05). csigniﬁcant diﬀerence with respect to PI and PHc of the same
group (P ≤ .05). ∗signiﬁcant diﬀerence with respect to PI and P-N of the same group (P ≤ .05) [33].
with two peaks at days 49 and 77. The HPIA activity was
undetectable in vitro prior to day 21, peaked from days 35
to 49, decreased at day 70, and was maintained thereafter.
The HPRA activity increased in vitro through days 7 to
56, decreased on day 63, and stabilized (see Figure 2). The
data was suggestive of the presence of potent PRF activity
prior to age 21. The inference drawn from this study was
supported by the ﬁndings of Bec´ u & Libertun (1982) and
Khorram et al. (1984) who reported potent age-related PRF
activities viz. TRH activity on day 1 and serotonergic PRF
activity on day 12 in male rats [45, 46]. Thus, the authors
concurred that age-related increase in serum prolactin levels
till day 28 could be attributed to the concomitant increase in
HPRA. Since the serum prolactin levels peaked again at day
70, despite stabilization of HPIA and HPRA activities, it was
inferredthatextrahypothalamicfactorslikegonadalestradiol
could be modulating the responsiveness of the pituitary
to dopamine. Alternatively, changes in the sensitivity of
pituitary to HPIA and HPRA could have led to increased
secretion at adulthood. This conclusion was based on the
prevailing hypothesis that the responsiveness of pituitary to
TRH, LHRH, DA, and estradiol undergoes a change from
puberty to adulthood [47–50]. It was inferred that the levels
of prolactin in circulation were determined by competitive
interactions between HPIA and HPRA, in accordance with
the suggestion of Matsushita et al. [51–53].
2.2. Testicular Factors. Prolactin can upregulate the synthesis
of testosterone in vivo through cognate receptors on the
Leydig cells of the testis [21, 22]. Based on intuitive logic
that end products are generally involved in the feedback
regulation of their hormonal stimulus, Gill-Sharma et al.
(1992) studied the inhibitory eﬀects, if any of testosterone
on prolactin secretion from rat PHc and intact pituitary
of normal and 7-day castrated rats in vitro [54]. The
authors could demonstrate the existence of a novel long
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Figure 2: Age-related changes in serum concentrations of prolactin
(dotted line), release of prolactin by whole pituitary (free release;
dashed line), hypothalamic prolactin-releasing activity (solid line),
andhypothalamicprolactin-inhibitingactivity(dotted-dashedline)
inmalerats.Valuesaremean ±SEMfromtwoseparateexperiments
and a minimum number of 14 animals per pooled group. ∗P<
.05 compared with preceding group; †P<. 05 compared with
hypothalamic prolactin-releasing activity at the same age (Student’s
t-test).Theinsetshowstheresultsfordays7and14onanexpanded
scale. The pituitary constructs were dissected out of 7 to 77 day-old
rats and incubated in DMEM for 4 hours at 37◦C. Prolactin was
estimated by RIA in the spent medium [35].
loop feedback mechanism for the regulation of prolactin
release in sexually competent male rats. They observed that
temporal release of prolactin from PHc of normal rats was
constant from 24 to 72 hours whereas that from PHc fromInternational Journal of Endocrinology 5
castrated and intact pituitary of normal and castrated rats
decreased from 24 to 72 hours of incubation in vitro (see
Figure 3). The release rates per 24 hours from normal PHc
constructs were signiﬁcantly lower than those from intact
pituitary constructs. The decrease in intact pituitary basal
release rates could be attributed to absence of hypothalamic
PRFs. The decrease in release from castrated PHc and intact
pituitary constructs was likely due to either the lack of PRFs
or availability of PIFs from the median eminence or both.
Coincubation with testosterone suppressed the temporal
secretionrateofprolactinfrombothPHcandintactpituitary
constructs of normal and castrated rats from 24 to 72 hours
in vitro. This observation was interpreted to suggest that
testosterone primarily acted on the pituitary lactotrophs of
both constructs to suppress prolactin secretion. Interest-
ingly, prolactin content of incubated pituitaries from PHc
constructs of normal rats was lower than that in intact
pituitaries but this diﬀerence disappeared after castration.
This observation was suggestive of suppressive eﬀects of
testosterone on prolactin synthesis. The inhibitory eﬀect of
testosterone became evident from the clear suppression of
prolactincontentbothinincubatedpituitariesfromPHcand
intact pituitaries of normal and castrated rats (see Figure 4).
The functionality of the 72-hour incubated pituitary con-
structs was demonstrable when all pituitary constructs not
exposed to testosterone, responded to a challenge dose of
100pm LHRH over a 4-hour period, with enhanced release
of LH and FSH, whereas androgen exposure counteracted
this response. The underlying mechanism through which
testosterone suppressed prolactin remains to be delineated
at the biochemical level. It can be speculated that prolactin
receptors expressed on the pituitary lactotrophs could have
mediatedthiseﬀect[55].Prolactinhasbeenreportedtoexert
a proliferative eﬀect on pituitary GH3 cells, expressing a
cognate receptor [56]. Hyperplasia of the adenohypophysis
is a hallmark of mice with dysfunctional prolactin signaling,
akin to the eﬀect observed in dopamine receptor D2-
deﬁcient mice, and suggestive of an antiproliferative role
of hypothalamic dopamine in antagonizing the prolactin
receptor-mediated growth response [14, 57]. It remains to be
seenwhethertestosterone canexert anantiproliferative eﬀect
on lactotrophs by downregulating the prolactin receptor,
observed in rat liver, to eventually reduce the level of
prolactin [58].
Gill-Sharma et al. (2001) had reported that the suppres-
sion of LH induced by low doses of estradiol in male rats did
not inhibit the secretion of testosterone presumably due to
an eﬀect of prolactin on its synthesis in the Leydig cells [59].
Testosterone inhibition however occurred at higher estradiol
doses only after enhancement of systemic prolactin levels
(see Table 3). Presumably, estradiol-induced enhancement
of rat prolactin secretion in vivo occurs through estrogen
response elements in its gene in the pituitary gland and leads
to infertility [60].
These studies had brought out the importance of pro-
lactin in maintaining testosterone homeostasis and fertility
status of male rats. Although the signiﬁcance of testos-
terone to male fertility is well documented, the studies
of Aleem et al. (2008) demonstrated for the ﬁrst time the
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Figure 3: Release of PRL by PHC and PI of normal and castrated
rats incubated with or without testosterone for 72 hours. Upper
panel. Pattern of release of PRL by PHC and PI of castrated rats,
incubated in absence ()o rp r e s e n c e( ) of testosterone (0.3mM)
for 72 hours. Values are mean ± SE and derived from 40 individual
incubations of PHC and 16 of PI, respectively. Lower panel. Pattern
ofreleaseofPRLbyPHCandPIofnormalratsincubatedinabsence
(◦)o rp r e s e n c e( •) of testosterone (0.3mM) for 72 hours. Values
are mean ± SE and derived from 15 individual incubations of PHC
and 16 PI, respectively. a, b, c denote signiﬁcant diﬀerence in values
at 48 hours as compared to 24 hours, at 72 hours as compared to
48 hours, and at 72 hours as compared to 24 hours, respectively.
p, q, r denote signiﬁcant diﬀerence in groups incubated with or
without testosterone at 24, 48, and 72 hours, respectively. ∗P ≤ .05.
Pituitary constructs were dissected out of normal or 7-day castrated
rats and incubated in DMEM with or without 0.3mM testosterone,
at 37◦C for 24–72hrs. Prolactin was analysed in the spent medium
by RIA [54].
consequencesofinadequatelevelsofthishormonetofertility
in male rats [61]s e e( Figure 5). They demonstrated that
blocking the androgen receptors with cyproterone acetate
(CPA), at a dose of 20mg/Kg/d for 15 days, to reduce the
bioavailability of testosterone, led to underprotamination
of epididymal sperm chromatin during spermiogensis in
sexually competent male rats (see Figure 5). Our recent
studies using CMA3 ﬂuorescent dye uptake assay have
conﬁrmed the earlier observations of Aleem et al. (2005) in
male rats. Cyproterone acetate-treated spermatozoa from
caput epididymides incorporated the CMA3 dye at the
GC-rich regions lacking protamine whereas the control rat
spermatozoa were unreactive (Figures 6(a)–6(d)) [62].
2.3. Hypophyseal Factors. In vitro studies on PHc system
further led to the development of several in vivo models6 International Journal of Endocrinology
Table 3: Eﬀects of estradiol 17β on serum hormones in adult male rat.
Estradiol 17β Plasma levels (ng/mL)
(μg/kg/d) LH FSH PRL T
00 .85 ±0.09 6.16 ± 0.32 122.37 ±6.17 2.17 ±0.31
0.1 0.89 ±0.108 5.58 ±0.498 115.80 ±4.03 1.50 ±0.17
10 0.54 ±0.109∗ 3.49 ±0.38∗ 120.60 ±4.70 1.44 ±0.19
100 0.43 ±0.09∗ 2.38 ±0.24∗ 255.50 ±17.9∗ 0.72 ±0.04∗
200 0.31 ±0.08∗ 2.67 ±0.17∗ 306.00 ±22.27∗ 0.84 ±0.09∗
300 0.19 ±0.05∗ 2.65 ±0.13∗ 370.00 ±13.60∗ 0.89 ±0.06∗
400 0.17 ±0.03∗ 2.48 ±0.56∗ 364.30 ±38.07∗ 0.83 ±0.10∗
1000 0.36 ±0.096∗ 2.98 ±0.18∗ 465.00 ±51.19∗ 0.63 ±0.097∗
Estradiol 17β was dissolved in saline by sonication and injected s.c. Male rats were mated at 60 days of treatment and serum hormones analyzed by RIA. All
values are expressed as mean ± SEM. Dose “0” represents control values. ∗denotes signiﬁcance at P ≤ 0.5 as compared to controls [59].
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Figure 4: Intrapituitary contents of PRL after incubation of
PHC (left-hand panel) and PI (right-hand panel) from normal
rats without (stippled bars) or with (hatched bars) testosterone
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or with (solid bars) testosterone (0.3mM) for 72 hours. Values
represent mean ± SE derived from 10 pituitaries. p, q, r,d e n o t e
signiﬁcant diﬀerences in groups incubated with or without testos-
terone, normal controls versus castrated controls and between
normal incubated with testosterone versus castrated incubated
with testosterone, respectively. ∗P ≤ .05. C: Incubation without
testosterone; T: Incubation with testosterone. Pituitary prolactin
content was estimated by RIA in PBS homogenates of pituitary
constructs incubated with or without 0.3mM testosterone for 72
hours and a challenge dose of LHRH at 37◦Cf o r4h o u r s[ 54].
in our lab with a view to understanding the physiological
relevance of the long and short feedback mechanisms
involved in the regulation of pituitary hormones. Prolactin
levels in the serum are known to be autoregulated through
prolactinreceptorsexpressedonthehypothalamicdopamin-
ergic neurons [63]. The autoregulation of prolactin, referred
to as the short feedback regulation, appears to be age-
related and is purported to be mediated either through
retrograde ﬂow in the hypophyseal stalk or via cerebrospinal
CP CP CP C C N
P1 6Kd
Figure 5: Western blots of protamine 1 in epididymal sperm of
sexually mature rats depicting the presence of 6Kd protamine 1
bands in control and absence in drug-treated rats. Cp: Cyproterone
acetate; C: Control; N: negative control. Basic proteins were
extracted in HCl, diﬀerentially extracted in trichloroacetic acid,
analysed on 15% acid urea PAGE. Western blotting was done with
1Hup 1N monoclonal antibody provided by Dr. Rod Balhorn [61].
ﬂuid (CSF) as a result of receptor-mediated uptake at the
choroid plexuses [64, 65]. Balasinor et al. (1992) carried out
studies in long-term castrated male rats and demonstrated
that CSF is a vital link between the circulating prolactin
and hypothalamic dopaminergic neurons that mediate its
autoregulation [66]. The authors observed that bilateral
castration of adult rats for 1, 3, 7, 14, 21, 28, 35, 46
days led to an increase in serum immunoactive prolactin
levels but those in the CSF, removed from cisterna magna,
displayed an inverse correlation (Figure 7). The turnover
of hypothalamic dopamine decreased in castrated rats sug-
gestive of a breakdown in the feedback mechanism in the
dopaminergic neurons. Apparently either systemic bioactive
prolactin was low or castration had led to a breakdown
of receptor-mediated uptake mechanism at the choroid
plexuses, as was suggested by low levels in CSF, with the
result that prolactin was not reaching the dopaminergic
neurons. Alternatively, dopaminergic neurons had become
refractory to prolactin. It could be reasoned that estradiol ofInternational Journal of Endocrinology 7
(a) (c)
(b) (d)
Control rat caput sperm CPA treated rat caput sperm
100× 40×
Figure 6: (a) Spermatozoa taken from untreated rats that have
not picked up the CMA3 chromatin stain viewed under ﬂuo-
rescent microscope at 100X magniﬁcation at 500–610nm exci-
tation/ﬂuorescence emission wavelength. (b) Spermatozoa of
untreated rats viewed under phase contrast objective at 40X mag-
niﬁcation. (c)-(d) Spermatozoa taken from the caput epididymides
of CPA-treated rats that have picked up the intense yellow CMA3
nuclear chromatin stain in GC-rich regions normally occupied by
protamine. Spermatozoa were ﬁxed in Carnoy’s ﬁxative and stained
with CMA3 dye in McIlvaine’s buﬀer. Staining was viewed under
ﬂuorescent microscope at 100X magniﬁcation at 500–610nm
excitation/ﬂuorescence emission wavelength.
adrenal origin could have gained access to the dopaminergic
neurons, downregulated dopamine turnover, and prevented
prolactin autoregulation. In conﬁrmation, a recent study by
Aleem et al. (2006) suggested that administration of exoge-
nous estradiol, at a dose of 100ug/Kg/d, raised its systemic
levels in male rats twofold within 10 days, concomitant
with a fourfold increase in the secretion of prolactin [67].
Furthermore, Aleem et al. (2005), also observed that when
the antiandrogen cyproterone acetate was administered to
male rats at a dose of 20mg/Kg/d for 15 days, a twofold
decrease in the serum estradiol levels produced a twofold
suppression of prolactin secretion [62].
3. Feedback Loops andImplications to
FertilityRegulation inMale Rat
These in vitro and in vivo studies have conﬁrmed that
gonadal steroids, estradiol, and testosterone together con-
stitute a long loop feedback mechanism for the regulation
of prolactin secretion at the pituitary hypothalamic level.
Whereas estradiol or long-term deprivation of testosterone
stimulatethesecretionofprolactinatthehypothalamiclevel,
suggestive of a positive long feedback, testosterone-mediated
suppression in vitro, and eﬀects of castration in vivo indicate
a negative feedback role at the pituitary.
The gaps in the information on the long loop feedback
regulation of prolactin emerged from the studies carried
out by Gill-Sharma et al. (2003) with the antipsychotic
ﬂuphenazine, a long-acting D2 dopamine receptor blocker,
administered to male rats at a dose of 1–3mg/Kg/d for
60 days to male rats [68]. The authors reported that
ﬂuphenazine competed with dopamine to block pituitary D2
receptors, leading to moderate hyperprolactinemia through
a compensatory upregulation of hypothalamic tyrosine
hydroxylase. Moderate increase in circulating prolactin led
to a signiﬁcant suppression of LH and FSH but not testos-
terone (Table 4). Grattan et al. (2007) reported that intrac-
erebroventricular injection of prolactin in estrogen-primed,
ovariectomized mice, led to the suppression of systemic LH
[69]. The authors demonstrated that both estradiol and
prolactin induced prolactin receptor in the gonadotropin
releasinghormone(GnRH)neuronsderivedfromtransgenic
mice expressing Green Fluorescent Protein (GFP) under the
control of GnRH promoter (GnRH-GFP) and implicated
it in LH suppression. More recently, Anderson et al. (2008)
have reported that chronic hyperprolactinemia induced
by dopamine antagonist, Sulpiride, suppressed LH pulse
frequency in estradiol-primed, ovariectomized rat [70]. The
authors further observed that estradiol augments the eﬀects
of Sulpiride-induced prolactin on the expression of prolactin
receptor and associated inhibitory signaling molecules viz.
STAT-5, SOCS-1 and 3, and CIS in the hypothalamic GnRH
neurons of estrogen-primed ovariectomized rat. The authors
suggested that prolactin inhibited the LH pulses in vivo since
prolactin-induced suppression of GnRH has already been
reportedinimmortalizedGT1celllinesderivedfrommurine
GnRHneurons[71].Suchaneﬀectofhyperprolactinemiaon
LH had also been reported by Bartke et al. (1977) [72]. The
chromatin of ﬂuphenazine-treated epididymal spermatozoa
was susceptible to denaturation in vitro. The fertilizing
potential of the poor quality of spermatozoa produced by
the ﬂuphenazine-treated rats was severely compromised as
indicated by reduction in litters sired. Sires displayed a
tendency to mate later than their untreated counterparts
indicative of an eﬀect on reproductive behaviour which was
considered to be due to direct eﬀects of moderately high
levels of prolactin on central incertohypothalamic neurons
(IHDA). The authors averred that the expected inhibition of
testosterone did not occur due to a direct eﬀect of prolactin
on its synthesis in the Leydig cells [68, 73]. In support of
the earlier observations suggestive of feedback repression
by testosterone, the in vivo study suggested that prolactin
could autoregulate its own secretion by upregulating the
synthesis of testosterone. It is tempting to speculate, on
the basis of the observations of Jeyaraj et al. (2005) and
Aleem et al. (2006) that prolactin could also be playing a
compensatory role in maintaining circulating testosterone
levels after sequestration of its circadian peak by estradiol-
induced androgen binding protein in the Sertoli cells of rat
testis [67, 74]. Thus the autoregulatory role of prolactin
appears to be exerted both at the hypothalamic and testicular
levels. It can be hypothesized on the basis of these results
that the eﬀects of moderate hyperprolactinemia on fertility
canbereversedbyautoregulationthroughthelongandshort
feedback loops.
However, further studies by Aleem at al. (2005) with
ﬂuphenazine in male rats did not support the corrective8 International Journal of Endocrinology
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Figure7:ComparativelevelsofPRLintheserumandCSFofmaleratsatdiﬀerentdaysfollowingcastration.Upperpanels.SerumPRLlevels.
Lower panels. CSF PRL levels. Values are expressed in terms of NIADDK-rat-PRL-RP-3. “c” denotes signiﬁcant diﬀerence at P<. 05 level
with respect to intact controls. Solid line with open circle (-◦-), dashed line with cross (–×–), and dotted line with closed circle (···•···)
represent data from castrated, intact, and sham operated rats, respectively. At each day of castration, values are expressed as mean ± SEM
of three or more determinations in duplicate of serum/CSF samples. In intact and sham-operated controls, each value is a mean of two
determinants in duplicate of serum/CSF. Small dots (•) denote value of each determination. Vertical bars represent SEM. Prolactin was
estimated by RIA in serum and CSF of normal and 1–46 day castrated rats [66].
Table 4: Eﬀects of ﬂuphenazine decanoate on fertility parameters and serum hormones in adult male rat.
Aﬀected Fluphenazine treatment (mg/kg/d) for 60 days
parameters 0 1 2 3
Prolactin, ng/ml 18.99 ±1.82 76.80 ±11.1∗ 82.53 ±10.6∗ 139.30 ±25.1∗
LH, ng/ml 1.13 ±0.26 0.23 ±0.04∗ 0.44 ±0.05∗ 0.54 ±0.05∗
FSH, ng/ml 7.72 ±0.26 5.43 ±0.44∗ 6.08 ±0.31∗ 6.00 ±0.22∗
Testosterone, ng/ml 2.60 ±0.14 2.17 ±0.17 2.40 ±0.20 2.32 ±0.24
Estradiol, ng/ml 82.00 ±9.51 114.2 ±21.37 0 .61 ±8.14 58.19 ±10.4
Sperm count, million/cauda 63.8 ±3.89 54.3 ±4.18 52.8 ±3.53 59 ±6.68
Potency, % 100 ±00 83.3 ±11.24 100 ±00 66.7 ±14.21∗
Fecundity, % 100 ±00 66.7 ±21.09 83.3 ± 16.67 50 ±22.36
Implantation sites, per rat 11.3 ±1.16 6.7 ±1.67 5.1 ±1.54∗ 5.4 ±1.69∗
Litters sired, per female 10.3 ±1.17 6.4 ±1.64 .8 ±1.49∗ 5.7 ±1.73∗
Fertility index, per rat 0.9 ±0.08 0.6 ±0.14 0.5 ±0.15∗ 0.5 ±0.15∗
Fluphenazine was dissolved in sesame oil and injected s.c. Male rats were mated at 60 days of treatment and serum hormones analyzed by RIA. Uterine horns
of mated females were exposed to count implantation sites, ovaries for corpora lutea. All values are expressed as mean ± SEM. Dose “0” represents control
values. ∗denotes signiﬁcance at P ≤ .05 as compared to controls. Potency = % mated females; fecundity = % male rats siring at least one viable pup; fertility
index = ratio of implantation sites to corpora lutea; litter size = number of pups per female [68].
hypothesis on fertility. They observed that in spite of
the compensatory feedback upregulation of testosterone by
prolactin, the FSH levels remained signiﬁcantly suppressed
[72, 75]. The eﬀects of FSH inhibition could be observed
on the mechanism of sperm chromatin condensation during
spermiogenesis in the testis. The authors observed that levels
of several key proteins involved in chromatin condensation
viz. cyclic adenosyl monophosphate regulatory element
modulator (CREMι), transition proteins, and protamine 1
were suppressed in the testis. The epididymal spermatozoa
of treated male rats lacked protamination and were loosely
packaged (see Figure 8). Recent in vitro studies carriedInternational Journal of Endocrinology 9
CCN F F
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Figure 8: Western blots of protamine 1 in epididymal sperm of
sexually mature rats depicting the presence of 6Kd protamine 1
bands in control and absence in drug-treated rats. F: Fluphenazine;
C: Control; N: negative control. Basic proteins were extracted in
HCl, diﬀerentially extracted in trichloroacetic acid, analysed on
15% acid urea PAGE. Western blotting was done with 1Hup 1N
monoclonal antibody provided by Dr Rod Balhorn [61].
out in our lab used ﬂuorescent CMA3 dye uptake assay
to demonstrate the protamination status of spermatozoa.
It was observed that spermatozoa taken from the caput
epididymides of untreated male rats did not incorporate
the CMA3 dye in the chromatin (see Figures 9(a)-9(b)).
The uptake of intense yellow CMA3 stain in the GC-rich
regions of ﬂuphenazine-treated epididymal sperm chro-
matin conﬁrmed the absence of protamination in these
regions where protamine normally binds (see Figures 9(c)-
9(d)). Thus, in spite of operational long and short feedback
mechanisms, moderate hyperprolactinemia was observed to
lead to production of poor quality spermatozoa.
4. Feedback Loops andFertility
Regulation in Men
Although it is not always possible to extrapolate the results
of animal studies to humans, studies carried out in our lab
by Juneja et al. (1991) suggested that feedback regulation
by gonadal steroids might be a conserved phenomenon
[76]. The authors determined the pattern of circadian
release of reproductive hormones from the hourly blood
samples drawn from normal young men (Table 5). Their
studiessuggestedthatthephysiologicalrelationshipapparent
between prolactin and testosterone in male rats was also
reﬂected in human males. The authors observed an inverse
correlation between the acrophase of circadian release of
bioactive prolactin with nadir of LH and a direct correlation
with that of the acrophase of testosterone release in men.
The temporal coupling of prolactin release between 20
and 23 hours followed by suppression of bioactive LH
b e t w e e n2 4a n d2h o u r sa n dp e a kr e l e a s eo ft e s t o s t e r o n e
between 1 and 5 hours was suggestive of a direct role
for prolactin in entraining testosterone release essential for
male behaviour while LH release was being restrained at
the level of hypothalamic GnRH and opiatergic neurons
(a) (c)
(b) (d)
Control rat caput sperm FLU treated rat caput sperm
100× 100×
Figure 9: (a) Spermatozoa taken from untreated rats that
have not picked up the nuclear chromatin stain viewed under
ﬂuorescent microscope at 100X magniﬁcation at 500–610nm
excitation/ﬂuorescence emission wavelength. (b) Spermatozoa of
untreated rats that have not picked up the stain viewed under phase
contrast objective at 100X magniﬁcation. (c)-(d) Spermatozoa
takenfromthecaputepididymidesofﬂuphenazine-treatedratsthat
have picked up the intense yellow CMA3 nuclear chromatin stain in
theGC-richregionsoccupied normally byprotamine.Spermatozoa
were ﬁxed in Carnoy’s ﬁxative and stained with CMA3 dye in
McIlvaine’s buﬀer. Staining was viewed under ﬂuorescent micro-
scopeat100Xmagniﬁcationat500–610nmexcitation/ﬂuorescence
emission wavelength.
and adenohypophyseal gonadotrophs by both the hormones.
Interestingly, peak release of testosterone appeared to have
led to suppression of prolactin between 9 and 11 hours
concomitantly with that of testosterone itself. Testosterone
nadir coincided with a surge of bioactive LH between 9 and
11 hours suggesting that the combined feedback inhibition
by the two hormones would have been released to allow
autopriming of the GnRH receptors on the gonadotrophs
and synthesis of LH receptors on the Leydig cells. The
suppression of testosterone probably led to a surge in
estradiol between 15 and 18 hours, presumably due to
activation of P450 aromatase in the Leydig cells. Estradiol
was then observed to entrain the prolactin peak between 20
and 23 hours. That the prolactin peak is of pituitary and not
extrapituitary origin could be averred from the fact that only
hypophyseal prolactin gene has estrogen response elements
in its promoter [60]. Their studies suggested that the tempo-
ral coupling between prolactin and testosterone could signify
a functional relationship that may be playing an important
role in the regulation of human male fertility. Although
diﬀerences have been reported between the prolactinergic
mechanismsbetweenratandhuman,particularlyintermsof
extrapituitary sites of synthesis, which would argue against
extrapolations, this particular study led to the tentative
conclusion that gonadal steroids, testosterone, and estradiol
could constitute a conserved physiological long feedback
mechanism between gonads and adenohypophysis which
likely ensures the circadian release of prolactin in systemic
circulation,andmaintainsmalefertilityandlibido.Thisview10 International Journal of Endocrinology
Table 5: Diurnal hormone variations in adult men.
Hormone/mL Mean Circadian Acrophase (h) Nadir (h)
concentration amplitude (range) (range)
T, ng 3.56 ±1.94∗ 3.1 ±0.8∗ 1–5 9–12
E2,p g 5 5 .9 ±26.9∗ 38 ±7.2∗ 15–18 24–2
BLH, mIU 55.4 ±6.25∗ 14.4 ±2.2∗ 9–12 24–2
ILH, mIU 7.4 ±1.7∗ 3 ±0.6∗ 1–5 15–17
BPRL, ng 4.9 ±1.7∗ 2.6 ±0.4∗ 20–23 9–11
IPRL, ng 11.6 ±2.0∗ 4.1 ±0.8∗ 23–4 11–15
Hormones in the hourly blood samples of healthy men were assayed by RIA. Hormone concentration and circadian amplitudes are expressed per milliliter
plasma. ∗ = SD. T = testosterone; ILH = immunoreactive LH (NIADDK-LER-907); BLH = bioactive LH (WHO 2nd IRP 78/549); BPRL = bioactive PRL
(NIAMDD-hPRL-I-6); IPRL = immunoactive PRL (NIAMDD-hPRL-I-6); E2 = 17-β-estradiol [76].
issupportedbythefactthatbothratandhumanhypophyseal
prolactin genes share estrogen response elements in their
promoters [77].
5. Conclusions
The results of our in vitro and in vivo studies suggest that
prolactin is a crucial hormone for the regulation of male
fertilitywithadeﬁnedontogeneticpatternofdevelopmentof
the hypothalamic releasing and inhibitory factors that deter-
mine its level in circulation at adulthood. Adult hypotha-
lami contain prolactin-responsive dopaminergic neurons for
autoregulation as well as stimulation of opiatergic neurons
involved in the inhibition of GnRH neurons. In addition
to the hypothalamic regulatory factors, adenohyphyseal
lactotrophs at adulthood express a testosterone-responsive
inhibitory mechanism for prolactin synthesis and estrogen-
dependent stimulatory mechanisms for prolactin secretion,
whereas Leydig cells in the testis express a prolactin-
dependent regulatory mechanism for testosterone synthe-
sis. The prolactin responsive mechanisms constitute the
biological substrates for the pituitary-hypothalamo-gonadal
feedback system in the male mammals, which relies on the
gonadal steroids, testosterone and estradiol for long-loop,
and prolactin for short-loop feedback mechanisms. These
mechanisms would operate to contain the adverse eﬀects of
reproductive stress and ensure that serum levels of prolactin
remainwithinthephysiologicalrange,becauseevenmild-to-
moderate hyperprolactinemia, if allowed to become chronic,
aﬀects the quality of mature spermatozoa and their fertiliz-
ing potential. Hyperprolactinemia also aﬀects reproductive
behaviourinspiteofnormaltestosteronelevels.Importantly,
whereas the eﬀects of acute hyperprolactinemia appear to be
mediated via testosterone inhibition, those due to moderate
hyperprolactinemia would be a consequence of FSH deﬁcits.
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